Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Crexendo (CXDO) EBT (2016 - 2025)

Crexendo's EBT history spans 15 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, EBT rose 123.42% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $5.4 million, up 184.33%, while the annual FY2025 figure was $5.4 million, 184.33% up from the prior year.
  • EBT reached $1.4 million in Q4 2025 per CXDO's latest filing, down from $1.5 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.7 million in Q3 2023 to a low of -$33.0 million in Q4 2022.
  • Average EBT over 5 years is -$1.5 million, with a median of $136000.0 recorded in 2023.
  • Peak YoY movement for EBT: plummeted 6166.67% in 2022, then soared 693.59% in 2024.
  • A 5-year view of EBT shows it stood at $820000.0 in 2021, then tumbled by 4130.24% to -$33.0 million in 2022, then surged by 100.24% to $78000.0 in 2023, then skyrocketed by 693.59% to $619000.0 in 2024, then skyrocketed by 123.42% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for CXDO's EBT are $1.4 million (Q4 2025), $1.5 million (Q3 2025), and $1.3 million (Q2 2025).